Restless Legs Syndrome

What restless legs syndrome is

Restless legs syndrome (RLS) — also called Willis-Ekbom disease — is a sensorimotor neurological disorder defined by an irresistible urge to move the legs, usually accompanied by uncomfortable sensations. The urge characteristically appears or worsens during periods of rest, eases with movement, and is most pronounced in the evening and at night. Patients commonly describe the sensations as creeping, crawling, tingling, aching, or "an itch deep in the bones that you can't scratch."

RLS exists in two forms. Primary (idiopathic) RLS often runs in families and tends to begin earlier in life, sometimes in childhood or adolescence. Secondary RLS is associated with another underlying condition — most commonly iron deficiency, pregnancy, end-stage renal disease, or the use of certain medications — and frequently improves when the underlying cause is treated.

The condition is more common than recognized. Roughly seven to ten percent of U.S. adults experience RLS symptoms; two to three percent have moderate-to-severe disease that warrants active treatment. RLS is twice as common in women as in men, and prevalence rises with age.

Recognizing the symptoms

The diagnosis of RLS rests on four essential clinical criteria established by the International Restless Legs Syndrome Study Group. All four must be present:

1. An urge to move the legs, usually accompanied or caused by uncomfortable or unpleasant sensations in the legs.
2. The urge worsens during periods of rest or inactivity — sitting still, lying down, long flights, theater seats, the first hour in bed.
3. The urge is partially or totally relieved by movement — walking, stretching, pacing, rubbing, or hot/cold application — for as long as the movement continues.
4. The urge is worse in the evening or at night than during the day, or only occurs in the evening or at night.

The vocabulary patients use is its own diagnostic clue. RLS sensations are described as creepy, crawly, prickly, burning, aching, throbbing, fidgety, or "ants under the skin." The sensations are typically deep in the muscles or bones rather than on the surface. They are usually felt in both legs (though one side may be worse), and in severe cases extend to the arms or trunk.

Sleep is what suffers. Many people with RLS describe sleep onset insomnia — they cannot stay still long enough to fall asleep — or fragmented sleep with frequent awakenings driven by leg discomfort or by periodic limb movements of sleep (PLMS), the brief repetitive leg jerks that occur during sleep in most RLS patients. Bed partners frequently notice the kicking before the patient identifies the daytime symptoms.

Why it happens

The pathophysiology of RLS centers on two interconnected systems: brain iron metabolism and the dopamine signaling that depends on it.

Iron is required for the synthesis of dopamine, the neurotransmitter that regulates movement. In RLS, brain iron is reduced — even when blood iron measurements look normal — and the dopaminergic pathways that suppress unwanted nighttime movement and sensation appear to function abnormally. This is why iron-deficient states reliably trigger or worsen RLS, and why dopaminergic medications can suppress symptoms in the short term.

The conditions and exposures most strongly associated with secondary RLS or with worsening of primary RLS include:

• Iron deficiency — even when serum iron is in the normal range, low ferritin (a marker of iron stores) frequently underlies RLS
• Pregnancy — particularly the third trimester; symptoms usually resolve postpartum but commonly recur in subsequent pregnancies
• End-stage renal disease and dialysis — RLS prevalence is sharply elevated in this population
• Certain medications — including some antidepressants, sedating antihistamines (a common ingredient in over-the-counter sleep aids and cold remedies), and dopamine-blocking antinausea or antipsychotic medications
• Family history — primary RLS is highly heritable, and the genetic component is well-established

Common triggers and aggravators

Even when the underlying biology is unchanged, day-to-day choices shift symptom severity meaningfully. The most consistent aggravators include:

• Caffeine — not always, but commonly; tolerance varies and afternoon caffeine is the more frequent culprit than morning
• Alcohol — particularly in the evening; the rebound during the second half of the night is a classic RLS pattern
• Tobacco and nicotine
• Sleep deprivation — RLS worsens after a poor night, creating a cycle
• Prolonged immobility — long flights, long drives, long meetings, hospital admissions; one reason RLS often surfaces during travel
• Over-the-counter sleep aids and cold remedies containing sedating antihistamines — these can dramatically worsen symptoms; many patients take them for sleep difficulty without realizing the medication itself is part of the problem
• Certain prescription medications — particularly some antidepressants and dopamine-blocking medications; never stop a prescribed medication without speaking to the prescribing clinician, but worth raising the connection

Eliminating evening caffeine and reviewing the medication list is the cheapest, fastest intervention available. Many mild cases improve substantially without any other treatment.

How RLS is diagnosed

RLS is a clinical diagnosis. The four IRLSSG essential criteria, taken together with the patient's symptom description, establish the diagnosis at the bedside. An overnight sleep study is generally not required.

Bloodwork that should always be done

Once RLS is suspected, the following labs are part of any reasonable initial workup:

• Ferritin — the most informative single test; reflects body iron stores
• Transferrin saturation (TSAT) — a complementary marker of iron availability
• Complete blood count, basic metabolic panel, and thyroid function — to identify other contributing conditions

The clinically meaningful ferritin threshold for RLS is not the standard "normal" cutoff most labs report. Current consensus from the IRLSSG and the American Academy of Sleep Medicine recommends iron repletion when ferritin is below 75 ng/mL or transferrin saturation is below 20%. Many patients are told their iron is "normal" at ferritin levels (e.g., 30–60 ng/mL) that nonetheless warrant repletion specifically for RLS.

When polysomnography is appropriate

An overnight sleep study is reserved for cases where the diagnosis is unclear, where another sleep disorder (such as obstructive sleep apnea) is suspected as a comorbidity, or where periodic limb movements need to be quantified for a specific clinical reason. PLMS frequently accompany RLS but PLMS without RLS symptoms are common and often clinically insignificant on their own.

What RLS is not

The differential diagnosis includes nocturnal leg cramps (painful muscle contractions, not an urge to move), peripheral neuropathy (numbness or tingling without the rest-relief-evening pattern), akathisia (a drug-induced restlessness that affects the whole body, not just the legs), and positional discomfort. The four URGE criteria are what distinguish RLS from each of these.

Treatment: iron first, lifestyle second

The first move in any RLS treatment plan is to correct iron stores, address modifiable triggers, and review the medication list. For many patients with mild-to-moderate disease, this is sufficient.

Iron repletion

If ferritin is below 75 ng/mL or transferrin saturation is below 20%, iron repletion is recommended. Two routes:

• Oral iron — typically taken every other day with vitamin C to enhance absorption, and away from coffee, tea, calcium, and certain medications that block absorption. Ferritin is rechecked after several months.
• Intravenous iron — a single-session infusion that raises ferritin substantially within weeks. Reserved for patients who cannot tolerate or do not respond to oral iron, who have very low starting ferritin, or who have malabsorption.

The target is generally a ferritin of 100 ng/mL or higher with transferrin saturation above 20%. Many patients experience meaningful symptom improvement within weeks to months of repletion, even when no pharmacotherapy is added.

Lifestyle measures

• Eliminate or substantially reduce evening caffeine, alcohol, and nicotine
• Review the medication list with a physician; flag sedating antihistamines, certain antidepressants, and dopamine-blocking antinausea or antipsychotic medications as candidates for substitution
• Establish regular, moderate exercise — vigorous late-evening exercise can worsen symptoms in some patients
• Maintain consistent sleep timing; sleep deprivation worsens RLS
• Keep the legs warm; some patients find that warm baths, heating pads, leg massage, or compression devices reduce symptom intensity

Pharmacotherapy when needed

When iron repletion and lifestyle changes are insufficient — or in moderate-to-severe RLS — daily medication is added. Modern guidelines have shifted the order of preference meaningfully over the past several years.

Alpha-2-delta calcium channel ligands

This class is now considered first-line for many patients with RLS, particularly those with significant pain or sleep onset difficulty. These medications act on calcium channels in the central nervous system to dampen the abnormal sensory and motor signaling. They do not carry the augmentation risk associated with dopamine agonists. Common considerations include sedation (often used to advantage at bedtime), dizziness, and weight gain.

Dopamine agonists

Dopamine agonists were first-line treatment for RLS for many years and remain effective in the short term. Their long-term use carries a serious complication called augmentation: paradoxical worsening of RLS, in which symptoms begin earlier in the day, spread to other body parts, and become more intense over time despite continued or increased treatment. Augmentation is now recognized as common in patients on long-term dopamine agonists and is the principal reason these medications have moved from first-line to second-line status for many patients.

If you have been on a dopamine agonist for years and your RLS seems to be worsening, that is a medical question worth raising with a sleep specialist. Augmentation is recognized, treatable, and not the patient's fault.

Opioids

Low-dose opioid therapy — most commonly with long-acting agents at carefully managed doses — is reserved for severe, refractory cases where iron repletion, alpha-2-delta ligands, and dopamine agonists have failed or caused intolerable side effects. This is specialist territory; the management balance is delicate and the decisions are not generalist territory.

The case for specialist involvement

RLS pharmacotherapy has changed substantially over the past decade. Patients who were started on dopamine agonists ten or fifteen years ago and never reassessed are common, and so is augmentation. A sleep specialist can interpret bloodwork against current consensus, plan iron repletion appropriately, sequence medications in line with current guidelines, and recognize and reverse augmentation when it occurs. For moderate-to-severe RLS, that conversation is worth having.